Journal profile · ENDOCRINOLOGY & METABOLISM
Endocrine Practice
ISSN 1530-891X · eISSN 1934-2403 · American Association of Clinical Endocrinology · UNITED STATES · Bimonthly · Founded 1995
Endocrine Practice: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.2; hybrid open access; APC about USD 3,480; median 86 days to acceptance (126 articles, last 24 months); community-reported acceptance: easy; 1,077 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Endocrine Practice is published by American Association of Clinical Endocrinology and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pituitary Gland Disorders and Treatments, Diabetes Management and Research and Thyroid Cancer Diagnosis and Treatment, together about 25.2% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Endocrine Practice, the flagship journal of the American Association of Clinical Endocrinology, is a double-blind, peer-reviewed journal publishing the latest clinical information on the treatment of diabetes, nutrition and obesity, thyroid disease, bone and parathyroid disease, lipid and cardiovascular health, and pituitary, gonad, adrenal, and neuroendocrine disorders.The journal is intended to enhance the clinical knowledge, treatment, and management of pediatric and adult endocrine diseases for the endocrinologist and endocrine care community, and publishes original research, clinical trials, reviews, commentaries, and editorials. Special articles include AACE's clinical guidance documents: clinical practice guidelines, consensus statements, and treatment algorithms.
From the journal's Aims & Scope
Research area (LetPub): ENDOCRINOLOGY & METABOLISM
Editor-in-chief Vin TangprichaPublisher website
Editorial board by country: 7 in mainland China (about 7%); most named United States 69, Italy 11, Mainland China 7, India 3, Japan 2 (101 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pituitary Gland Disorders and TreatmentsMedicine9.2%
- Diabetes Management and ResearchMedicine8.2%
- Thyroid Cancer Diagnosis and TreatmentMedicine7.7%
- Thyroid Disorders and TreatmentsMedicine6.8%
- Diabetes Treatment and ManagementMedicine6.2%
- Parathyroid Disorders and TreatmentsMedicine5.4%
- Adrenal and Paraganglionic TumorsMedicine5%
- Hyperglycemia and glycemic control in critically ill and hospitalized patientsMedicine4.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.2LetPub ·
- Impact factor (publisher)
- 4.4Publisher website ·
- CiteScore 2026-06
- 7.5LetPub ·
- CiteScore (publisher)
- 7.5Publisher website ·
- SJR 2026-06
- 1.35LetPub ·
- SNIP 2026-06
- 1.52LetPub ·
- h-index
- 77LetPub ·
- h-index
- 127OpenAlex ·
- i10-index
- 2,293OpenAlex ·
- 2-year mean citedness
- 0.87OpenAlex ·
- Self-citation rate
- 4.5%LetPub ·
- Share of gold OA articles
- 13.99%LetPub ·
Volume
- Articles per year
- 189LetPub ·
Articles by year OpenAlex count · 12,467 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 1,020 | 155 | 86 |
| 2025 | 1,077 | 274 | 1,017 |
| 2024 | 687 | 206 | 1,330 |
| 2023 | 578 | 337 | 2,111 |
| 2022 | 700 | 95 | 3,599 |
| 2021 | 721 | 172 | 3,314 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
86 daysMedian, submission to acceptance · P25–P75 56 days – 122 days
- Acceptance to online
- median 8 days (126 articles)
- Submission to online
- median 99 days
- Sample
- 126 articles with submission and acceptance dates (530 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 6 daysPublisher website ·
- First decision after review
- 31 daysPublisher website ·
- Submission to acceptance
- 75 daysPublisher website ·
- Acceptance to publication
- 6 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,480 / EUR 3,260 / GBP 2,790 / JPY 431,620 | — | — | |
| Publisher website | USD 450 / USD 805 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted7, with length limits
- commentariesCommentaries should reflect the author's views on a timely topic of interest to the endocrine community, limited to 1,500 words, 1 figure or table, and 15 refer…Length not stated
- commentaryCommentaries should reflect the author's views on a timely topic of interest to the endocrine community, limited to 1,500 words, 1 figure or table, and 15 refer…main text ≤ 1,500 words · figures and tables ≤ 1 · references ≤ 15
- editorialThere will be an editorial handling fee assessed for non-invited manuscripts accepted for publication. Corresponding authors will receive an invoice after publi…Length not stated
- letters to the editorLetters to the editor must be original material that has not been submitted or published elsewhere. Restrict length to 500 words and include no more than three …main text ≤ 500 words
- original articleOriginal articles should be restricted to clinical or basic studies, particularly translational research, which add new information to the etiology, treatment, …main text ≤ 3,500 words · figures and tables ≤ 10 · references ≤ 40
- review articleesses as original articles. The text of review articles must be limited to 3,500 words, with a maximum of 6 figures and tables (total) and up to 8main text ≤ 3,500 words · figures and tables ≤ 6 · references ≤ 80
- review articlesAll review articles are subjected to the same peer-review and editorial processes as original articles. The text of review articles must be limited to 3,500 wor…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, …
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors should complete the declaration of compe…
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Subscribers may reproduce tables of contents or prepare lists of articles includ…
Source ↗Publisher website ·- Open access Open Access
Authors complete a Journal Publishing Agreement upon acceptance. Model summary
Please visit our Open Access page from the Journal Homepage for more information.
Source ↗Publisher website ·- Peer review Peer review
This journal operates a double-blind review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's dec…
Source ↗Publisher website ·- Preprints Preprints
Preprints can be shared anywhere at any time and do not count as prior publication. Model summary
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- American Association of Clinical Endocrinology
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1995
- ISSN
- 1530-891X
- Electronic ISSN
- 1934-2403
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Endocrine Practice
What CAS zone is Endocrine Practice in?
In the 2025 upgraded edition of the CAS Journal Ranking, Endocrine Practice is in Zone 3 of Medicine, and in Zone 4 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Endocrine Practice?
The latest impact factor listed by LetPub is 4.2; CiteScore 7.5, h-index 127.
How long does peer review take at Endocrine Practice?
Based on the dates recorded on 126 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 86 days (interquartile range 56–122 days); the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Endocrine Practice based?
Of the 101 board members whose country the journal's board page names, 7 (about 7%) are in mainland China; the countries named most often are United States (69), Italy (11) and Mainland China (7). Counted from the institutions listed on the board page; for reference only.
Which databases index Endocrine Practice?
According to LetPub and DOAJ records, Endocrine Practice is indexed in SCIE and Scopus. The journal's website also lists PubMed; that list has not been checked against each database.
Is Endocrine Practice open access, and what is the APC?
Endocrine Practice is a hybrid journal. For open-access publication: APC about USD 3,480.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .